CIAS
ABMD

Capital Investment Advisory Services’s Abiomed Inc ABMD Stock Holding History

Capital Investment Advisory Services’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-655
Closed -$212K – 779
2020
Q4 		$212K Sell
655
-200
-23% -$55.3K 0.03% 405
2020
Q3 		$237K Sell
855
-50
-6% -$14.4K 0.04% 316
2020
Q2 		$219K Buy
+905
New +$182K 0.04% 295
2019
Q4 		– Sell
-425
Closed -$76K – 1333
2019
Q3 		$76K Buy
425
+125
+42% +$27K 0.02% 456
2019
Q2 		$79K Buy
+300
New +$79.6K 0.02% 443

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Capital Investment Advisory Services's ABMD Position: Q1 2021 in Review

Capital Investment Advisory Services sold out of Abiomed Inc (ABMD) in Q1 2021, closing a stake of 655 shares — an estimated $212K sold.

Capital Investment Advisory Services first reported a position in ABMD in Q2 2019 and held it in 5 quarters. The position peaked at $237K in Q3 2020. 487 funds tracked by Wall St. Rank hold ABMD as of Q1 2021.

  • Capital Investment Advisory Services reported no remaining Abiomed Inc position as of Q1 2021 after selling out during the quarter.
  • Capital Investment Advisory Services sold 655 Abiomed Inc shares in Q1 2021, an estimated $212K.
  • Capital Investment Advisory Services first reported a position in Abiomed Inc in Q2 2019 and held it in 5 quarters.
  • Capital Investment Advisory Services's Abiomed Inc position peaked at $237K in Q3 2020.
  • 487 funds tracked by Wall St. Rank held Abiomed Inc as of Q1 2021.

Based on Capital Investment Advisory Services's 13F filing for Q1 2021, filed 5 May 2021.